SCHEMBL3597083

SCHEMBL3597083

Cc1ccc(-c2ccc3ccn(CC(=O)NCCN4CCC[C@H]5CCCC[C@@H]54)c3c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 9/20 0.46
▸ HSD17B10 Q99714 7/20 0.46
▸ TSHR P16473 5/20 0.46
▸ CYP3A4 P08684 3/20 0.46
▸ CYP2C19 P33261 2/20 0.46
▸ CYP2D6 P10635 2/20 0.46
▸ KMT2A Q03164 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ GRIN2B Q13224 3/20 0.42
▸ HTT P42858 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ ALDH1A1 P00352 3/20 0.41
▸ HPGD P15428 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ USP2 O75604 1/20 0.39
▸ POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3597085 1.00 KDM4E (0.46) KDM4EHSD17B10TSHRCYP3A4CYP2C19
SCHEMBL13115610 1.00 KDM4E (0.46) KDM4EHSD17B10TSHRCYP3A4CYP2C19
SCHEMBL13115690 0.90 KDM4E (0.39) KDM4EHSD17B10TSHRCYP3A4CYP2C19
SCHEMBL3594735 0.90 HSD17B10 (0.57) KDM4EHSD17B10TSHRCYP3A4CYP2C19
SCHEMBL3600661 0.83 KDM4E (0.55) KDM4EHSD17B10TSHRCYP3A4CYP2C19
SCHEMBL3604427 0.83 GRIN2B (0.45) KDM4ECYP3A4CYP2C19KMT2AGRIN2B
SCHEMBL3605190 0.83 KMT2A (0.49) KDM4EHSD17B10TSHRCYP3A4CYP2C19
SCHEMBL3607170 0.82 KDM4E (0.51) KDM4EHSD17B10TSHRCYP3A4CYP2C19
SCHEMBL3597719 0.82 KMT2A (0.48) KDM4EHSD17B10TSHRCYP3A4CYP2C19
SCHEMBL3602569 0.82 KMT2A (0.48) KDM4EHSD17B10TSHRCYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7807704-B2 Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2 CHEMOCENTRYX, INC. (US) 2010-10-05 — — US disclosed
US-20070275965-A1 CXCR4 modulators CHEMOCENTRYX, INC. (US) 2007-11-29 — — US disclosed
WO-2007115231-A2 CXCR4 MODULATORS CHEMOCENTRYX, INC. (US) 2007-10-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275965-A1 CXCR4 modulators CXCL12, CXCR4, CXCR1 KDM4E 4801/4885HSD17B10 3413/4885TSHR 1277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback